Thaul, Susan, <br/><br/>
FDA user fees and the regulation of drugs, biologics, and devices  :  comparative analysis of S. 3187 and H.R. 5651  / 
 Food and Drug Administration user fees and the regulation of drugs, biologics, and devices  Comparative analysis of S. 3187 and H.R. 5651 
Susan Thaul [and six others]. 
 - [Library of Congress public edition]. 
 - 1 online resource. 
 - Report / Congressional Research Service ;  R42564 .
 - CRS report ;  R42564. .
<br/><br/> The CRS report home page provides access to all versions published since 2018 in accordance with P.L. 115-141; earliest version dated 2012.  GPO Cataloging Record Distribution Program (CRDP). 
<br/><br/>Report includes bibliographical references. 
<br/><br/><label>LCCN: </label>2020230750 
<br/><br/><label>Subjects--Corporate Names: </label><br/>United States. Food and Drug Administration --Rules and practice.<br/>United States. Food and Drug Administration Safety and Innovation Act. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Medical instruments and apparatus industry--Law and legislation--United States.<br/>Drugs--Prices--Law and legislation--United States.<br/>Medical instruments and apparatus--Costs.--United States<br/>User charges--Government policy--United States.
<br/><br/><label>GPO Item No.: </label>0807-A-07 (online) 
<br/><br/><label>Gov. Doc. Class. No.: </label>LC 14.23:R 42564/